Designing influenza polymerase acidic endonuclease inhibitors via 'privileged scaffold' re-evolution/refining strategy
Hits:
Institution:药学院
Title of Paper:Designing influenza polymerase acidic endonuclease inhibitors via 'privileged scaffold' re-evolution/refining strategy
Journal:Future Medicinal Chemistry
First Author:鞠翰
All the Authors:展鹏,刘新泳
Document Code:249354C68061490CB49745233C338605
Volume:11
Issue:4
Page Number:265
Translation or Not:No
Date of Publication:2019-02
Release Time:2019-10-04
Prev One:Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant
Next One:Resurrecting the Condemned: Identification of N-Benzoxaborole Benzofuran GSK8175 as a Clinical Candidate with Reduced Metabolic Liability